Lam Research Corp (LRCX)

Investment Committee Summary

Investment Thesis

At $310 on 25 August 2026, Lam Research trades near 33 times forward earnings, a multiple that capitalises a normalised wafer-fabrication-equipment cycle rather than a trough. The business has two halves with different economics: new etch and deposition systems, the larger share of the mix, which track global equipment spending and swing with it; and the customer-support business — spares, service and upgrades on an installed base of chambers — which is smaller but recurring, carries the higher margin, and cushions the systems cycle. The blended operating margin near 33% and a balance sheet carrying net cash of ~$1.8B both reflect that mix. The structural argument is content per wafer: high-bandwidth-memory stacks and advanced packaging add etch and deposition steps independent of unit volume, so revenue can grow even when wafer starts do not. Against that, triangulated fair value of $303 stands -2% against spot, the probability-weighted expected value is $331 and the twelve-month target is $331; the shares are fairly valued against the weighted anchors, which is what produces the HOLD. Within the shared AI Compute Stack frame the price sits between Digestion and Sustained Build. The single most damaging risk is export control: rules restricting advanced-node tools, spares and service can strand installed-base revenue the recurring line is assumed to keep.

Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.

The dashboard below is the whole argument on one page: spot ($310) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Anti-Thesis (The Real Bear Case)

The bear case is not a soft quarter; it is the structural state the scenario tree carries at the heaviest downside weight — an equipment-spending reset compounded by China restriction. Memory is the most volatile component of industry equipment spending and the largest swing factor in systems revenue; memory capital budgets can fall by roughly a third in a year when customers digest. A large minority of revenue has come from China, and export rules already restrict advanced-node tools, spares and service to certain fabs; further listings can strand installed-base service revenue that is otherwise the defensive half of the model. Domestic Chinese equipment makers are substituting at trailing nodes, which turns a cyclical air pocket into permanent share loss. In that state systems revenue falls, the support business no longer cushions it, absorption reverses so the operating margin drops well below the level near 33% the base case assumes, and the market re-rates the name from a structural-growth multiple toward a cyclical one. That is AI Capex Bust rather than Digestion, and the structural target sits below the 52-week low.

Key Debate

P/E Multiple explains 71% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.

What the Market Is Pricing In

At the current price, the market pays 32.8× consensus forward EPS, vs the house DCF terminal 30.0×, and a peer median 33.4×. The house DCF sits 8% below spot, so the market is pricing in more than the house case — roughly 0.9pp of revenue CAGR.

Variant perception: the house view is below-consensus, and the thesis is primarily growth-driven.

Scenario Analysis

The scenario tree spans a structural 'Structural — WFE Reset / China Restriction' downside ($79.55) to a 'Bull — Supercycle Re-Rate' bull case ($612); the probability-weighted blend (PWEV $331) is +7% versus spot.

Share-count charge: none applied. The probability-weighted value above is the gross per-share figure — no annual dilution is deducted — stock-based compensation runs at 1.7% of revenue; free cash flow net of SBC is $4.50B. SBC is therefore disclosed, not charged: read the per-share figures as before dilution.

Scenario rationale — the driver path behind every target:

Valuation Triangulation

Three weighted anchors — an intrinsic dcf, a scenario-weighted pwev and a monte carlo median (student-t + regime switching) — read them with their basis in mind. The Monte Carlo, the DCF terminal and any peer re-rate key off a market multiple, so they are not fully independent; only discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat three numbers as three independent votes.

The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name sum-of-parts, peer P/E re-rate are not computed, so 25% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way.

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

Monte Carlo — the outcome distribution

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $297 and 46% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (71% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.

DCF — the cash-flow anchor

Independent of the market multiple: a 5-year path, WACC 10.0%, 30.0x terminal FCF multiple → $286. This anchor is deliberately the heaviest (47%): it is the valuation least hostage to the current multiple regime.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median EV/Revenue multiple implies $359; the peer-median forward P/E is 33.4x, but the engine carries no P/E-implied price for this name (no forward-EPS basis at the peer step). A premium is only justified by superior growth/margins; otherwise it is multiple risk. Excluded from the weighted blend — shown only as a market cross-check.

Across all anchors the spread is 22% of the median — moderate (healthy method disagreement — read the blend with care).

Sensitivity

DCF/share — WACC × terminal multiple

DCF/share — revenue CAGR Δ × op-margin Δ

Tornado — DCF/share swing by driver (widest first)

Company lever — SoP/share vs Systems (new equipment - etch & deposition) multiple (AI re-rating) (base 18.0x)

Peer Quality & Weighting

Quality-weighted forward P/E: 33.4× (simple median 33.4×). Direct peers count 100%, segment 50%, broad 25%.

Historical-range cross-check: 52-week range $93.59–$438, centre $203 (-35% vs spot); spot sits at the 63rd percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

That ratio compares triangulated upside against the probability-weighted bear target, not the extreme tail; with a leg missing it is withheld rather than computed from a magnitude. Bull case (Bull — Supercycle Re-Rate): $612.

Company Overview & Business Model

Lam Research Corp — TECHNOLOGY · SEMICONDUCTOR EQUIPMENT & MATERIALS. Lam Research Corporation is an American corporation that engages in the design, manufacture, marketing, and service of semiconductor processing equipment used in the fabrication of integrated circuits. Its products are used primarily in front-end wafer processing, which involves the steps that create the active components of semiconductor devices (transistors, capacitors) and their wiring (interconnects).

How it makes money.

Edge. Narrow moat. Authored moat rationale withheld pending re-authoring.

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Named Exposures

China & export controls (FACT/ESTIMATE/INFERENCE)

Memory cycle & HBM / AI capex (FACT/ESTIMATE/INFERENCE)

Industry Context — AI Compute Stack

This name sits in the AI Compute Stack cluster as a supplier — wafer-fab equipment name. Lagged & memory-weighted: capex → fab/HBM capacity build → etch/deposition WFE demand. AI lifts content per wafer (HBM, advanced packaging). Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.

Value chain: MSFT (buyer (hyperscaler)) · GOOGL (buyer (hyperscaler)) · AMZN (buyer (hyperscaler)) · META (buyer (hyperscaler)) · NVDA (supplier — AI accelerators) · LRCX (supplier — wafer-fab equipment) · MU (supplier — HBM / memory)

Mapping note: name-level 'Upcycle — Leading-Edge / HBM Capex' (20%) + 'Bull — Supercycle Re-Rate' (8%) map to cluster Supercycle (28%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.

On the cluster's key downside — AI Capex Bust (FY27 aggregate −30%+ (to ~$350B)) — this name implies 20% vs the cluster house view of 22% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.

Structure: Concentration — Demand: 4 hyperscalers ≈ 60-70% of AI capex. Supply: NVDA dominates accelerators; TSMC is the single leading-edge fab; 3 HBM makers. (FACT/ESTIMATE). Barriers — CUDA software lock-in, HBM/CoWoS packaging supply, leading-edge fab access, networking (NVLink). (FACT). Pricing Power — Sits with NVDA today (~75% gross margin); erodes if custom ASICs (Google TPU, AWS Trainium, Meta MTIA) and AMD take share, or inference shifts to cheaper compute. (INFERENCE). Substitution Risk — Custom silicon, model-efficiency gains (DeepSeek-style $/token collapse), inference-vs-training mix shift, and the circular vendor-financing of neoclouds/OpenAI. (INFERENCE).

Balance Sheet & Liquidity

Balance-sheet data as of 2026-06-30 (Alpha Vantage).

Capital Allocation

Free-Cash-Flow Quality

Accounting quality: SBC 1% of revenue; cash conversion (OCF/NI) 81% — cash-backed.

Competitive Moat

Moat sources:

• Installed-base lock-in / CSBG spares-service recurring revenue (~37% of sales)
• Etch & ALD process-recipe co-development with leading memory/foundry customers (switching cost)
• Duopoly/oligopoly structure in deposition & etch (LRCX/AMAT/TEL) at leading edge
• Absence of moat at trailing nodes where AMEC/Naura substitute

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q3): management +0.64 vs analyst floor +0.00 → delta +0.64 (n=33 mgmt / 21 Q&A; 91st pctile across the S&P book, z +1.5).

Flag: ELEVATED — management unusually upbeat vs the analyst floor relative to peers (disconfirmation watch).

News (last 365d, 1739 articles): avg ticker sentiment +0.21 (bullish 22% / bearish 3%)

Consensus & Market Expectations

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Catalyst Calendar

• 2026-10-15 (~52d) — US BIS export-control rule review / potential entity-list update (authored)
• 2027-03-01 (~189d) — SEMICON / customer HBM4 capacity commitments (authored)

Forecast Track Record

• EPS surprise: beat 100% of the last 8 quarters; average surprise +6.4%.
• Prior-forecast backtest (16 snapshots, 2026-04-24→2026-08-20): directional hit-rate 81%; mean predicted -12.3% vs realised -3.0%. Disconfirming track record is reported, not suppressed.

Catalyst Timeline

5 catalysts in the next 90 days (of 14 tracked). Importance 1–3; confidence 0–1.

_Sources: extended.catalysts, data/catalysts/.json, data/catalysts/macro.json, AV DIVIDENDS, opex 3rd-Friday calc.

Regulatory & Legal Risk

Probabilities and sensitivities are analyst estimates, not market-implied.

Scenario Macro & Key Risks

Scenario-macro rows withheld pending re-authoring: 5 carrying a scenario taxonomy this name no longer uses — recorded in the narrative quarantine ledger.

Decision Rules (Machine-Checked)

Stance: Hold — 0 bullish / 0 bearish / 0 caution rules triggered of 6 evaluable (0 lacked data).

Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is a portfolio-management signal and does not modify the published research rating.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

• FY revenue ($B) < 30.35 (next reported fiscal year). (rationale withheld pending re-authoring — frozen figure or verdict)
• Probability-weighted fair value (PWEV) at the next re-run < 310.17 (any scheduled re-run). (rationale withheld pending re-authoring — frozen figure or verdict)
• Share price (close) < 79.55 (5 consecutive sessions). (rationale withheld pending re-authoring — frozen figure or verdict)

Fact / Inference / Speculation

• FACT: Spot $310; 52-week range $93.59–$438; engine rating HOLD; house target $331 (+7%). (source: Alpha Vantage 2026-08-24, 25 August 2026)
• INFERENCE: Triangulated FV $303 (-2% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
• SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.

Conviction Score

Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.

71.6/100 (confidence band 62.6–80.6), 95th percentile of 858 covered names (as of 2026-08-24). Weighted composite under config ros-1.19.0 — every component and its inputs below.

Score history: 70.8 → 70.8 → 72.6 → 71.5 → 71.5 → 72.0 → 71.8 → 71.8.

Probability-Weighted Return Profile

Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.

The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.

Expected Alpha

Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).

A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.

Probability Cross-Checks

Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.

Authored set: 5 scenarios, probabilities summing to 1.0, mean target $331.1.

Factor Exposures

Cross-sectional percentiles over 858 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.

Portfolio Interaction (Focus Book)

This name is in the top-conviction focus book. Equal-weight book vol 9.8%; diversification benefit 71.5% vs the gross-weighted average single-name vol — combining correlation, the short leg hedging the long leg, and net exposure below 1.0; not diversification alone.

Options Intelligence

Preferred structure: Long Stock. The selector reads the equity view (direction) and the volatility surface — nothing here re-prices the chain.

• no directional edge and options are cheap — options add little; hold the stock
• Direction neutral from the overlay conviction/rating (read-only input).
• IV/RV at the 9th percentile of the cross-section → low vol bucket. This is the measure that selects the structure above: it ranks how rich this name's implied vol is against its own realised vol, relative to other names.
• IV term structure is in contango (longer-dated richer, slope +3.9pp) — favour longer-dated ownership (LEAPS) or calendars that are long the cheaper front.
• No live-chain Long Stock was priced for this name — shown as the indicated strategy; size against a freshly pulled chain.

IV term structure (contango, slope +3.9pp): 32-DTE 61% · 88-DTE 65% · 389-DTE 65%

No live-chain Long Stock was priced for this name — shown as the indicated approach; size against a fresh chain.

Alternatives: . IV rank shown via the cross-sectional IV/RV percentile (interim) (advisory); structure selected on the cross-sectional IV/RV percentile. Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.

Position Sizing Framework

Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.

Options Overlay

A defined-risk way to express the HOLD equity view. Chain as of 2026-08-24 — end-of-day marks — indicative, not executable quotes.

Market signals — ATM IV 61.0% (subdued regime) · expected move ±14.2% (2026-09-25) · put/call OI 1.14 · ATM Δ 0.54 / Θ -0.35 / ν 0.36. Direction: NEUTRAL (implied return -2.3% to triangulated fair value $303.05).

Covered Call (if held) (Income / neutral) — Short 330 C · 2026-09-25 · premium $14.05 · yield 4.5% · priced from the listed chain (EOD marks)

Converts a near-fair holding into income by agreeing to sell at a higher strike — worth weighing when upside looks limited near fair value and being called away is acceptable. Illustrative — no outcome is implied or guaranteed.

Put Spread (income) (Income / would-own) — Short 285 P / Long 265 P · 2026-10-02 · net $6.15 · net entry $278.85 · yield 2.2% · RoR 44.0% · max loss $13.85 · priced from the listed chain (EOD marks)

Gets paid to wait for a lower entry, with the tail capped: the sold put collects premium while the cheaper long wing below it caps the maximum loss at the spread width — a defined-risk alternative to a naked cash-secured put.

Protective Collar (if held) (Hedge) — Long 280 P / Short 340 C · 2027-03-19 · net $10.97 · floor -10.0% · cap +10.0% · priced from the listed chain (EOD marks)

For a holder who wants to stay invested but cap risk: the sold call funds most of the protective put, fencing the position into a band — a way to ride out a de-rating without selling.

Indicative options structures — a defined-risk expression of the equity view, model-and-market illustrated from the last-close chain. NOT personalised advice or an executable quote; premiums, IV and greeks move intraday. Options carry the risk of total loss of premium. Not a registered financial adviser.

Rating Bridge

Rating = HOLD because:

• Probability-weighted scenario value implies +7% vs spot
• Monte Carlo median implies -4% vs spot
• DCF fair value implies -8% vs spot — but this is terminal-value sensitive (exit-multiple $286 vs Gordon $155, 46% apart), so it carries less weight
• Bear case (Structural — WFE Reset / China Restriction) downside is -74% vs spot
• Net: the valuation anchor itself sits 2.3% below spot, so there is no reward leg to weigh against the bear case and the reward-to-risk ratio is withheld rather than computed off a negative upside. The rating is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.

Model Appendix

DCF — line items

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 3% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 10.0% · Σ PV(FCF) $54B + PV(terminal) $299B = EV $353B; + net cash $1.8B → equity $354B ÷ diluted shares $1.24B = $286/share (exit-multiple terminal).

• Gordon terminal at 2.5% → $155/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
• Incremental ROIC on the forecast capex ≈ 54% vs WACC 10.0% → above WACC — the build is value-creative.

Peer set

Implied prices at the peer medians: EV/Rev → $359 (no P/E-implied price — no forward-EPS basis at the peer step).

Weighted fair-value math

Assumption Register

Sensitivity-ranked drivers (widest fair-value swing first): Revenue CAGR ±3pp (73.0); Terminal × ±15% (72.0); Op margin ±3pp (43.0); WACC ±1pp (24.0); Capex intensity ±15% (8.0).

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Research Provenance

Load-Bearing Assumptions

DCF: WACC 10.0%, terminal multiple 30×, FY+5 revenue $46B. Triangulation leans 47% on DCF, 33% on PWEV, 20% on the Monte Carlo median.